Background and Purpose-Current guidelines for commercial motor vehicle (CMV) drivers to return to driving after a TIA or stroke was last reviewed in 1988. Updated recommendations are presented based on recent evidence. Methods-A 3-member medical expert panel chosen by the U.S. Department of Transportation's Federal Motor Carrier Safety Administration used findings of systematic literature review up to January 2008 to provide updated recommendations for return to driving for CMV drivers after TIA or stroke. Results-Evidence from the systematic review showed that TIA patients are at increased risk for stroke, and stroke patients are at increased risk for motor vehicle crash. Although no studies provide direct evidence of predictability of crash risk of CMV drivers using outcomes of neuropsychological assessments, there is evidence that certain neuropsychological tests can identify on-road driving performance after stroke. Conclusions-The medical expert panel recommended driving cessation for 1 year after a TIA or stroke, and return to driving a CMV should be allowed only after successful completion of a comprehensive neurological evaluation, neuropsychological assessments, and on-road testing. (Stroke. 2010;41:2991-2996.)
T he primary mission of the U.S. Department of Transportation's Federal Motor Carrier Safety Administration is to reduce crashes, injuries, and fatalities involving commercial motor vehicles (CMV), including large trucks and buses. One mechanism to facilitate this effort is to update current standards and guidelines and to develop new medical fitness standards and guidelines for medical examiners who are responsible for certifying drivers as fit for duty.
This report summarizes updated recommendations of a panel of 3 experts in the field of stroke medicine (henceforth termed the medical expert panel) based on an extensive review of current literature. 1 Until this time, Federal Motor Carrier Safety Administration's physical qualification standards and guidelines for medical examiners to determine fitness to drive after stroke and TIA were last formulated in 1988 and (available at http://www.fmcsa.dot.gov/factsresearch/research-technology/publications/medreports.htm). Other countries have similar guidelines that are used in determining medical fitness to drive, such as the Canadian Medical Association Drivers Guide, 7 th edition.
Materials and Methods
The Federal Motor Carrier Safety Administration asked the panel to address 3 key questions: among individuals who have experienced a TIA, what is the risk of experiencing a future stroke?; are individuals who have experienced a stroke at an increased risk for a motor vehicle crash (ie, crash risk)?; and can neuropsychological testing of individuals who have experienced a stroke predict crash risk? A comprehensive systematic literature search was commissioned by Federal Motor Carrier Safety Administration and conducted by Emergency Care Research Institution (J. T. Reston, M. Noble) and Manila Consulting Group (J. Williams, S. J. Tregear) before being reviewed by the medical expert panel. The systematic search accessed several electronic databases, including MEDLINE, PubMed (PreMEDLINE), EMBASE, PsycINFO, CINAHL, TRIS, and the Cochrane Library (through January 10, 2008). The main search terms used in this analysis are presented in the Appendix (available at http://stroke.ahajournals.org), and the search strategy is summarized in Figure 1 . Abstracts of identified studies were retrieved and "gray literature" was manually searched. All documents were screened against a set of general and key question-specific inclusion criteria that were determined a priori. General inclusion criteria were that articles must: (1) have been published in the English language; 2 (2) be a full-length publication (abstracts and letters to the editor were excluded); (3) have included Ն10 subjects per group with enrolled subjects aged 18 years or older; and (4) be the most complete version and the primary reference to avoid double-counting of individuals if the same study was reported in multiple publications.
Other criteria that were specific to the 3 questions included studies that: (1) were limited to individuals with TIA or minor stroke only (no reversible ischemic neurological deficits); (2) determined the risk of stroke associated with TIA or the prevalence of TIA in subjects who had a stroke; (3) included a comparison group of comparable subjects who did not have TIA or a minor stroke; (4) evaluated the relationship between people who had a stroke to measures of driver safety, such as direct evidence of crash risk and measures of driving-related performance (laboratory and experimental); and (5) evaluated neuropsychological test scores and crash incidence or driving performance in persons who had a stroke.
The systematic literature search took into account the quality of the individual studies for each key question the interplay between the quality, quantity (effect size), robustness, and consistency of the overall body of evidence. Provisions to perform meta-analysis, heterogeneity testing, and sensitivity analysis 3 were made a priori. However, given the paucity of the data identified by our searches, these analyses were not performed. The strengths of evidence ratings assigned to the different types of conclusions are defined in Table 1 .
Results: Findings of Evidence Report
The search strategy identified 375, 89, and 20 articles for questions 1, 2, and 3, respectively. Of these only 13, 6, and 12 articles fulfilled the study criteria and therefore formed the evidence base of this report for questions 1, 2, and 3. The revised version of the Newcastle-Ottawa Quality Assessment Scale for these studies showed that they were of moderate to low quality with limited generalizability to the stroke population. Thirteen case-control or cohort studies 4 -16 showed an elevated risk of stroke in individuals who experienced a TIA compared to controls. In Figure 2 , synthesis of the data from the 13 studies showed a relationship between the relative risk (RR) for stroke as a function of time since experiencing a TIA. This was based on pooled analyses of data from cohort studies that assessed stroke risk in patients who had experienced a TIA compared to patients who had not experienced a TIA. The RR represents the 95% confidence interval of the effect estimate for the time points of 1, 6, 12, 24, and 36 months. At 1 month after TIA, patients had a 65-fold increase in the risk of stroke compared to controls. Compared to controls, the RR decreases to 16 times at 6 months, 6 times at 12 months, 3 times at 24 months, and 1.6 times at 36 months. The data suggest that the risk is highest in the first month after TIA and remains relatively high during the first year after an event.
Additional studies showed that after a TIA, the initial stroke risk may vary 17, 18 and the presence of hypertension, diabetes mellitus, and older age predicted stroke risk at 1 year. 19 Other events may occur soon after TIA, such as hospitalizations for cardiovascular events (2.6%), deaths (2.6%), and recurrent TIA (12.7%). 20 
Summary
There is strong evidence that persons with a history of TIA are at an increased risk for stroke. There is moderate evidence that increase in stroke risk is highest immediately after TIA and decreases as a function of time since the event. Strong Evidence supporting the qualitative conclusion is convincing. It is highly unlikely that new evidence will lead to a change in this conclusion.
Moderate
Evidence supporting the qualitative conclusion is somewhat convincing. There is a small chance that new evidence will overturn or strengthen our conclusion. We recommend regular monitoring of the relevant literature for moderate-strength conclusions.
Minimally acceptable Although some evidence exists to support the qualitative conclusion, this evidence is tentative and perishable. There is a reasonable chance that new evidence will either overturn or strengthen our conclusions. We recommend frequent monitoring of the relevant literature.
Insufficient
Although some evidence exists, the evidence is insufficient to warrant drawing an evidence-based conclusion. We recommend frequent monitoring of the relevant literature.
Quantitative Conclusion (Stability of Effect Size Estimate)
High
The estimate of treatment effect in the conclusion is stable. It is highly unlikely that the magnitude of this estimate will change substantially as a result of the publication of new evidence.
Moderate
The estimate of treatment effect the conclusion is somewhat stable. There is a small chance that the magnitude of this estimate will change substantially as a result of the publication of new evidence. We recommend regular monitoring of the relevant literature.
Low
The estimate of treatment effect included in the conclusion is likely to be unstable. There is a reasonable chance that the magnitude of this estimate will change substantially as a result of the publication of new evidence. We recommend frequent monitoring of the relevant literature.
Unstable
Estimates of the treatment effect are too unstable to allow a quantitative conclusion to be drawn at this time. We recommend frequent monitoring of the relevant literature.
Question 2: Are Individuals Who Have Experienced a Stroke at an Increased Risk for a Motor Vehicle Crash?
In 2 of 3 studies with sample sizes of 51 and 17, respectively, stroke survivors had increased risk for vehicle crashes after adjustment for number of miles driven. 21, 22 The only study that did not adjust for miles driven did not find an increased risk of vehicle crash. 23 An on-road driving study showed that stroke survivors were at increased risk for motor vehicle crashes because of poor driving skills. 24 The direct evidence for vehicular crash risk after stroke is limited by the small size of the evidence base and low-to-moderate quality of the studies. Indirect evidence from 2 simulator-based driving studies 25, 26 are inconsistent and also are limited by absence of direct evidence.
Summary
At present, there is minimally acceptable evidence available to suggest that drivers who have experienced a stroke are at an increased risk for crash because the magnitude of the crash risk was not determined. 
There is moderate evidence that certain neuropsychological tests can predict the outcome of driving performance measured by a road test or in-clinic driving evaluation. Whether neuropsychological tests can predict actual crash risk, especially in CMV drivers, cannot be determined because there is a lack of evidence from which such conclusions can be drawn.
Recommendations of the Medical Expert Panel
The medical expert panel made 5 recommendations based on review of the current literature and levels of evidence of their findings. The recommendations are presented here and are summarized in Table 2 .
Recommendation 1: Single TIA or Minor Stroke and CMV Driver Certification
The medical expert panel recommended that all individuals who have experienced a single TIA or minor stroke should be immediately excluded from driving a CMV. Individuals who have remained free of recurrent TIA or minor stroke for a period of at least 1 year and who are otherwise physically fit may qualify to drive a CMV. Such individuals must demonstrate that they are able to perform their normal duties by undergoing a thorough evaluation of their physical and mental function by a qualified neurologist or other physician who is well-versed and competent in the diagnosis and treatment of patients with TIA or stroke, and who is knowledgeable about the sequelae of stroke. Individuals with severe disabling stroke needing assistance or supervision in their activities of daily living should be disqualified from driving because of the severity of their impairments.
The certification process should include a mandatory on-road driving evaluation. This takes into consideration the length, width, and weight of the CMV and other challenges to driving, including ability to see objects in the blind angle and the spatial requirements of driving a CMV.
Justification
The risk for stroke recurrence is highest immediately after a TIA or minor stroke. This risk remains relatively high for the first year. Traffic accidents only take a few seconds to occur, even before the symptoms associated with a TIA or minor stroke resolve.
Recommendation 2: Preventive Treatment After a Single TIA or Minor Stroke Event
Individuals who receive immediate (secondary) prophylactic treatment after a TIA are at reduced risk for TIA or stroke recurrence compared to those who do not receive treatment or receive treatment later. However, medical expert panel rec- 
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ommendations for these patients are the same as those stated in recommendation 1.
Justification
Study findings suggest that preventive drug treatments such as antiplatelet agents, antihypertensives, statins, and anticoagulation for atrial fibrillation can significantly reduce the risk of stroke recurrence after a TIA or minor stroke. 38 -40 Although immediate treatment for cerebral ischemia reduces the risk of recurrence by 80%, it does not totally eliminate this risk. Because the risk of recurrence of cerebral ischemia remains relatively high in the first year after the initial cerebral ischemic event, CMV drivers should not be allowed to drive during this time period.
Recommendation 3: Annual Recertification
The medical expert panel recommended that individuals who have experienced a TIA or stroke and who have been certified as being physically qualified to drive a CMV (see recommendations 1 to 3) should be recertified on an annual basis. The annual recertification process should include a thorough neurological assessment performed by a qualified neurologist 41 or other physician who is well-versed and competent in the diagnosis and treatment of patients with TIA or stroke and who is knowledgeable about the sequelae of stroke. Driving history should also be considered and should include the number of total miles driven, evidence of traffic violations, and crash involvement (at fault or not at fault).
Any history of occurrence of seizures consequent to stroke should also be taken into consideration. The medical expert panel recommends that individuals who experience a seizure after a stroke should not be certified as physically qualified to drive a CMV for at least 1 year, even if they are neurologically intact after stroke. This certification process should include mandatory on-road evaluation.
Justification
Approximately 5% to 20% of all individuals who have a stroke will have subsequent seizures, [42] [43] [44] but epilepsy (recurrent seizures) will develop in only a small subset of this group. The prospective, multicenter Seizures after Stroke Study Group, 42 which enrolled 1897 patients, found an overall incidence of seizures of 8.9%. Recurrent seizures consistent with the development of epilepsy occurred in 2.5% of the patients during a mean follow-up of 9 months. Seizures were more common in the hemorrhagic than in the ischemic stroke group (10.6% vs 8.6%). Most early-onset seizures occurred during the first 2 days after ischemic stroke. 42, 45 Risk factors for poststroke seizures included cortical location, 44 large lesions involving multiple lobes of the brain, 46 and initial stroke severity. 47 Early-onset seizures after stroke commonly have been simple partial seizures (61%), followed by secondarily generalized seizures (28%). 48 Late-onset seizures were more likely to be secondarily generalized. 43, 49 Status epilepticus occurred in 9% of poststroke seizures and was associated with higher functional disability. 50 Findings in these studies suggest that individuals who experience a stroke-related seizure would have experienced a severe stroke and are usually severely and permanently debilitated. Consequently, such individuals will be unable to operate a CMV. Any history of TIA or stroke recurrence should result in permanent disqualification from operating a CMV.
Recommendation 4: Neuropsychological Tests and On-Road Evaluation
The medical expert panel recommended that although neuropsychological tests (eg, Figure of Rey test, Motor- Individuals who have remained free of recurrent TIA or minor stroke for a period of at least 1 year and who are otherwise physically qualified may qualify to drive a CMV.
Such individuals must demonstrate that they are able to perform their normal duties by undergoing a thorough evaluation of their physical and mental function by a qualified neurologist. Individuals who have experienced severe disabling stroke resulting in their needing assistance or supervision in their activities of daily living are to be disqualified from driving because of the severity of their impairments.
The certification process should include an on-road driving evaluation, as is required in 49 CFR §391.31 for new truck drivers. Considering the length, width, and weight of the CMV and other challenges to driving, including ability to see objects in the blind angle and the special spatial requirements of driving a CMV, on-road testing after 1 year cessation because of a TIA or stroke should be mandatory.
Preventive Treatment After a Single TIA or Minor Stroke Event
The recommendations for these patients are the same as those stated here.
Annual Recertification
The annual recertification process should include a thorough neurologic assessment performed by a qualified neurologist.
Driving history should also be considered and should include the number of total miles driven, evidence of traffic violations, and crash involvement (at fault or not at fault).
Any history of TIA or stroke recurrence, history of traffic violation, including reckless driving, speeding, and running traffic light/signs, driving under the influence of alcohol or any illicit drug, or history of involvement in an "at fault" accident should result in permanent disqualification from operating a CMV.
Individuals who experience a seizure after a stroke should not be certified as physically qualified to drive a CMV.
Neuropsychological Tests and On-Road Evaluation
Neuropsychological tests (eg, figure of Rey test, the dot cancellation test, road sign recognition test, and square matrix test from the SDSA and the motor-free visual perception test) may provide a reasonable guide as to which person will likely pass a driver evaluation test; on-road evaluation should remain the gold standard for certification.
CMV indicates commercial motor vehicle; SDSA, stroke driver screening assessment.
free Visual Perception Test, the dot cancellation test, road sign recognition test, and square matrix tests from the Stroke Driver Screening Assessment) may provide a reasonable guide as to which person will likely pass a driver evaluation test, the ability of neuropsychological tests to predict likelihood of poststroke crash is unknown, and the on-road driving test remains the gold standard for certification.
Justification
One must confirm not only that the individuals who have experienced a TIA or stroke have the mental and physical ability to operate a CMV but also that such individuals must demonstrate that they are actually able to operate a CMV by passing an on-road evaluation, which remains the closest approximation to natural driving performance. On-road test has been used in many studies as the single criterion of driving ability after stroke. 30, 31, [33] [34] [35] [36] In a retrospective study that included 104 stroke survivors, performance in an on-road test was the most important predictor of the decision of being fit or not to drive. 32 Although a standardized on-road test is a valid and reliable test of driving ability after stroke, 51, 52 it does not test the full potential for accident proneness. This is because of the unpredictability of traffic during testing and the experience of the examiner in assessing persons with TIA or minor stroke.
Conclusion
The medical expert panel recommended that: (1) CMV drivers with TIA or minor stroke should not be allowed to drive a CMV in the first year after the cerebral ischemic event because this is the period associated with increased relative risk of recurrence of cerebral ischemia; (2) CMV drivers who have been free of TIA or minor stroke for 1 year should undergo a thorough mental and physical evaluation by a certified neurologist or other physician who is well-versed and competent in the diagnosis and treatment of patients with TIA or stroke, and who is knowledgeable about the sequelae of stroke, and must pass a pre-driving assessment including a practical road test and subsequently should have a yearly history of traffic violations assessed before being recertified as safe to drive a CMV; and (3) neuropsychological tests provide a reasonable guide as to which person will likely pass a driver evaluation test; however, the ability to predict the likelihood of a poststroke crash risk is unknown.
Apart from the direct recommendations for determining fitness to drive a CMV after a TIA or stroke, the medical expert panel recommended that the Federal Motor Carrier Safety Administration should consider funding research investigations that will provide direct evidence of the relationship between TIA or minor stroke and CMV driver crash risk and identify the value of a U.S.-adapted version of the Stroke Driver Screening Assessment in predicting on-road performance of drivers, including CMV drivers, after TIA and minor stroke.
